Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1992 Apr 15;146(8):1331–1334.

Prevalence of bloodborne infective agents among people admitted to a Canadian hospital.

M Louie 1, D E Low 1, S V Feinman 1, B McLaughlin 1, A E Simor 1
PMCID: PMC1488539  PMID: 1313326

Abstract

OBJECTIVE: To determine the prevalence rates of hepatitis B surface antigen (HBsAg) and antibodies to the human immunodeficiency virus (anti-HIV) and the hepatitis C virus (anti-HCV) among people admitted to an urban Canadian hospital. DESIGN: Anonymous unlinked serosurvey. SETTING: A 420-bed teaching hospital in Toronto. PARTICIPANTS: All 3000 patients admitted to the hospital on weekdays from January to June 1990. An attempt was made to exclude those who were readmitted during the study period. INTERVENTIONS: Serum samples from all the patients were tested for HBsAg and anti-HIV, and 1306 samples were also tested for anti-HCV by means of enzyme immunosorbent assays; reactions were confirmed by means of specific antibody neutralization or immunoblot assay. MAIN RESULTS: The prevalence rates of HBsAg, anti-HIV and anti-HCV were 2.1% (95% confidence interval [CI] 1.6% to 2.6%), 0.6% (95% CI 0.3% to 0.9%) and 0.5% (95% CI 0.1% to 0.9%) respectively. CONCLUSIONS: This is the first report defining rates of infection with these bloodborne agents among patients admitted to a Canadian hospital. The observed rates likely reflect the patient population served by our hospital and do not necessarily apply to other Canadian centres. The results support the use of universal precautions in health care settings.

Full text

PDF
1331

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti A. Diagnosis of hepatitis C. Facts and perspectives. J Hepatol. 1991 May;12(3):279–282. doi: 10.1016/0168-8278(91)90827-x. [DOI] [PubMed] [Google Scholar]
  2. Alter M. J., Gerety R. J., Smallwood L. A., Sampliner R. E., Tabor E., Deinhardt F., Frösner G., Matanoski G. M. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis. 1982 Jun;145(6):886–893. doi: 10.1093/infdis/145.6.886. [DOI] [PubMed] [Google Scholar]
  3. Arevalo J. A., Washington A. E. Cost-effectiveness of prenatal screening and immunization for hepatitis B virus. JAMA. 1988 Jan 15;259(3):365–369. [PubMed] [Google Scholar]
  4. Feinman S. V., Krassnitzky O., Sinclair J. C., Wrobel D. M., Berris B. Prevalence and significance of hepatitis B surface antigen in a general hospital. Can Med Assoc J. 1975 Jan 11;112(1):43–45. [PMC free article] [PubMed] [Google Scholar]
  5. Gerberding J. L. Current epidemiologic evidence and case reports of occupationally acquired HIV and other bloodborne diseases. Infect Control Hosp Epidemiol. 1990 Oct;11(10 Suppl):558–560. [PubMed] [Google Scholar]
  6. Gordin F. M., Gibert C., Hawley H. P., Willoughby A. Prevalence of human immunodeficiency virus and hepatitis B virus in unselected hospital admissions: implications for mandatory testing and universal precautions. J Infect Dis. 1990 Jan;161(1):14–17. doi: 10.1093/infdis/161.1.14. [DOI] [PubMed] [Google Scholar]
  7. Henderson D. K., Fahey B. J., Willy M., Schmitt J. M., Carey K., Koziol D. E., Lane H. C., Fedio J., Saah A. J. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med. 1990 Nov 15;113(10):740–746. doi: 10.7326/0003-4819-113-10-740. [DOI] [PubMed] [Google Scholar]
  8. Kelen G. D., Fritz S., Qaqish B., Brookmeyer R., Baker J. L., Kline R. L., Cuddy R. M., Goessel T. K., Floccare D., Williams K. A. Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med. 1988 Jun 23;318(25):1645–1650. doi: 10.1056/NEJM198806233182503. [DOI] [PubMed] [Google Scholar]
  9. Kiyosawa K., Sodeyama T., Tanaka E., Nakano Y., Furuta S., Nishioka K., Purcell R. H., Alter H. J. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med. 1991 Sep 1;115(5):367–369. doi: 10.7326/0003-4819-115-5-367. [DOI] [PubMed] [Google Scholar]
  10. Major C. J., Read S. E., Coates R. A., Francis A., McLaughlin B. J., Millson M., Shepherd F., Fanning M., Calzavara L., MacFadden D. Comparison of saliva and blood for human immunodeficiency virus prevalence testing. J Infect Dis. 1991 Apr;163(4):699–702. doi: 10.1093/infdis/163.4.699. [DOI] [PubMed] [Google Scholar]
  11. Rhame F. S., Maki D. G. The case for wider use of testing for HIV infection. N Engl J Med. 1989 May 11;320(19):1248–1254. doi: 10.1056/NEJM198905113201905. [DOI] [PubMed] [Google Scholar]
  12. St Louis M. E., Rauch K. J., Petersen L. R., Anderson J. E., Schable C. A., Dondero T. J. Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States. The Sentinel Hospital Surveillance Group. N Engl J Med. 1990 Jul 26;323(4):213–218. doi: 10.1056/NEJM199007263230401. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES